Advances in our understanding of cell biology and assay technologies have resulted in the use of cell-based assays far earlier in the drug discovery workflow. This creates a significant challenge for labs; traditional cell-based approaches are not designed for the high throughput screening demands of early stage candidate identification. Labs therefore need to find new ways of working to deal with the needs of modern drug discovery pipelines.

Download this whitepaper to discover a rapid, high-throughput solution for cell-based screening assays that:

• Uses minimal amounts of sample
• Accelerates time-to-results
• Has multiple applications